News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter
Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

Celebrities and Cancer
Cancer Types
Radiotherapy
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Immune Oncology
Oncologist Near Me
OncoDaily Party 2025

Childhood Cancer
Health Policy
Hall of Fame
OncoIndustry
Public Health
Oncology Tech
Blog Posts
BIGR
Global Cancer Movement
History
Oncolibrary
OncoThon 2025
Yvonne Award 2025

Mar / 2026

March 2026
M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

« Feb

OncoDaily IO OncoDaily GI Hemostasis Today Fertility News

Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter

60 questions about SCLC with Dr. Greg Kalemkerian Part 2

60 questions about SCLC with Dr. Greg Kalemkerian Part 2

CAPItello-281 Trial at ASCO GU : Capivasertib Plus Abiraterone in PTEN-Deficient mHSPC

CAPItello-281 Trial at ASCO GU : Capivasertib Plus Abiraterone in PTEN-Deficient mHSPC

15 Posts Not To Miss From ASCO GU 2026

15 Posts Not To Miss From ASCO GU 2026

Yüksel Ürün: ASCO Guideline Update on WBC Growth Factors in Chemotherapy

Yüksel Ürün: ASCO Guideline Update on WBC Growth Factors in Chemotherapy

Rezatapopt Shows Early Activity in TP53 Y220C–Mutated Solid Tumors

Rezatapopt Shows Early Activity in TP53 Y220C–Mutated Solid Tumors

LITESPARK-022 Update: Adjuvant Belzutifan + Pembrolizumab in High-Risk Clear Cell Renal Cell Carcinoma

LITESPARK-022 Update: Adjuvant Belzutifan + Pembrolizumab in High-Risk Clear Cell Renal Cell Carcinoma

UC San Diego School of Medicine Launches New Precision Medicine Therapeutics in Oncology Program

UC San Diego School of Medicine Launches New Precision Medicine Therapeutics in Oncology Program

Ilana Yurkiewicz

Sep 24, 2025 6:58 pm

Voices

Shivi Kumar’s Research at the Women in Medicine Summit at Chicago

Shivi Kumar’s Research at the Women in Medicine Summit at Chicago

Jul 21, 2025 6:11 pm

Blog Posts

Ilana Yurkiewicz: What Every Internist Should Know about Caring for Cancer Survivors

Ilana Yurkiewicz: What Every Internist Should Know about Caring for Cancer Survivors

Dec 4, 2024 9:54 am

OncoDaily 100

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Nov 7, 2024 5:04 am

Positive

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 9

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 9

Apr 13, 2024 11:18 am

Blog Posts

Ilana Yurkiewicz: New podcast out today on FRAGMENTED, my cancer survivorship practice, and navigating a broken health care system

Ilana Yurkiewicz: New podcast out today on FRAGMENTED, my cancer survivorship practice, and navigating a broken health care system

Headlines

Joanna Metzner-Sadurski: Honored to Join ASCO Health Policy Committee

Stephen V Liu: Results With ORCHARD

Eder Martins Appointed Vice President, US Franchise Head - Lung Cancer at AstraZeneca

Robin Zon Presents ASCO Edge Module Focused on Leadership in Oncology

Why Chemotherapy Stops Working: The Science of Cancer Drug Resistance

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

Oncology OncoDaily cancer fight against cancer Global fight against cancer Breast Cancer cancer care ASCO Lung cancer Cancer research Headlines ESMO MD Anderson Cancer Center immunotherapy NSCLC cancer treatment cancer awareness Research colorectal cancer ASCO24 Childhood Cancer clinical trials prostate cancer FDA AACR UICC Dana-Farber Cancer Institute American Cancer Society European Cancer Organisation SIOP chemotherapy Robert Orlowski Myeloma NCI Vivek Subbiah National Cancer Institute American Society of Clinical Oncology Myeloma Paper of the Day Pancreatic Cancer healthcare Paolo Tarantino AI radiation oncology cervical cancer IASLC WHO ASCO25 Zainab Shinkafi-Bagudu multiple myeloma Memorial Sloan Kettering Cancer Center

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}